Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03533582
Title Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Oncology Group
Indications

hepatoblastoma

hepatocellular carcinoma

Therapies

Cisplatin + Doxorubicin + Gemcitabine + Oxaliplatin + Sorafenib

Cisplatin + Doxorubicin + Fluorouracil + Vincristine Sulfate

Carboplatin + Cisplatin + Doxorubicin + Etoposide

Carboplatin + Cisplatin + Doxorubicin + Irinotecan + Vincristine Sulfate

Cisplatin

Cisplatin + Doxorubicin + Sorafenib

Cisplatin + Doxorubicin

Carboplatin + Cisplatin + Doxorubicin

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.